protein phosphatase magnesium-dependent 1 delta inhibitors (NCI/NIH OTT)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprotein phosphatase magnesium-dependent 1 delta inhibitors (NCI/NIH OTT)
Drug Alias NamePP2Cdelta inhibitors (NCI/NIH OTT)PPM1D inhibitors (NCI/NIH OTT)cyclic phosphopeptide inhibitors (NCI/NIH OTT)Wip1 inhibitors (NCI/NIH OTT)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtein phosphatase 1D inhibitors
TargetsProtein phosphatase 1D
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A